SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sangamo Therapeutics, Inc. SGMO
SGMO 0.461+0.2%Nov 28 12:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (164)11/14/2005 2:37:33 AM
From: tuck  Read Replies (1) of 368
 
>>RICHMOND, Calif., Nov. 11 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO - News) announced today that it has obtained commitments from a select group of institutional investors and Dow AgroSciences, LLC to purchase approximately 5.08 million shares of common stock, at a price of $3.85 per share, for gross proceeds of approximately $19.5 million, before fees and expenses. The closing is expected to take place on Wednesday, November 16, 2005, subject to the satisfaction of customary closing conditions. JMP Securities and Piper Jaffray & Co. acted as joint lead placement agents, with Leerink Swann & Company acting as co-placement agent for this offering.

In addition, Michael Wood, a director of the Company, has agreed to purchase 235,849 shares of common stock from the Company, at a price of $4.24 per share, the closing bid price on November 10, 2005, for total proceeds of approximately $1.0 million. The closing for this purchase is scheduled to occur coincident with the closing of the sale to institutional and strategic investors.<<

About a 10% discount, but no warrants, could be worse . . .

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext